![Nicholas Saccomano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Saccomano
Keine laufenden Positionen mehr
Vermögen: 30 799 $ am 31.05.2026
Profil
Nicholas A. Saccomano is currently President, Chief Executive Officer & Director at OnKure Therapeutics, Inc. He serves as Director at Kestrel Therapeutics, Inc., Modulo Bio, Inc., BioLoomics, Inc., Latigo Biotherapeutics, Inc., and Think Bioscience, Inc. since 2022.
Formerly, Dr. Saccomano was Chief Executive Officer & Director at OnKure, Inc. from 2023 to 2024.
He was Director at KromaTid, Inc. He was Senior Vice President at Pfizer Inc. from 1984 to 2008.
He was Chief Scientific Officer at Bend Research, Inc. in 2008.
He served as Venture Adviser at Torrey Pines Investment, Inc. He was Chief Science Officer at Array BioPharma, Inc. from 2019 to 2022.
He was Chief Technology Officer at SomaLogic Operating Co., Inc. from 2009 to 2014.
Dr. Saccomano earned a doctorate from the Graduate School of Arts & Sciences at Columbia University and an undergraduate degree from The State University of New York in 1980.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,02 % | 01.04.2026 | 7.333 ( 0,02 % ) | 30 799 $ | 31.05.2026 |
Aktive Positionen von Nicholas Saccomano
| Unternehmen | Position | Beginn |
|---|---|---|
Think Bioscience, Inc.
 Think Bioscience, Inc. BiotechnologyHealth Technology Develops small-molecule drugs | Direktor/Vorstandsmitglied | 06.09.2022 |
Latigo Biotherapeutics, Inc.
 Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops non-opioid pain medicines | Direktor/Vorstandsmitglied | - |
BioLoomics, Inc.
 BioLoomics, Inc. BiotechnologyHealth Technology Provides novel drug screening services to analyze drug action and toxicity | Direktor/Vorstandsmitglied | - |
Kestrel Therapeutics, Inc.
 Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology development company | Direktor/Vorstandsmitglied | - |
Modulo Bio, Inc.
 Modulo Bio, Inc. BiotechnologyHealth Technology Discovers treatments and digital platform that harness the neuron immune system for the benefit of patients and their families | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Nicholas Saccomano
| Unternehmen | Position | Ende |
|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 |
SomaLogic Operating Co., Inc.
 SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology Operates as a protein biomarker discovery and clinical diagnostics company | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2014 |
Bend Research, Inc.
 Bend Research, Inc. Pharmaceuticals: MajorHealth Technology Provides drug delivery and formulation development technologies | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2008 |
| PFIZER INC. | Corporate Officer/Principal | 01.05.2008 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Nicholas Saccomano
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
94
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
OnKure, Inc.
 OnKure, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing epigenetic therapies for the treatment of cancer | Health Technology |
KromaTid, Inc.
 KromaTid, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology Operates as a protein biomarker discovery and clinical diagnostics company | Health Technology |
The State University of New York
 The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bend Research, Inc.
Bend Research, Inc. Pharmaceuticals: MajorHealth Technology Provides drug delivery and formulation development technologies | Health Technology |
Torrey Pines Investment, Inc.
 Torrey Pines Investment, Inc. Investment ManagersFinance Torrey Pines Investment invest in companies located in the United States. The firm targets companies operating in the field of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirement. It acts as lead investor and also makes co-investments. | Finance |
Graduate School of Arts & Sciences (Columbia University )
 Graduate School of Arts & Sciences (Columbia University ) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioLoomics, Inc.
BioLoomics, Inc. BiotechnologyHealth Technology Provides novel drug screening services to analyze drug action and toxicity | Health Technology |
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops non-opioid pain medicines | Health Technology |
Kestrel Therapeutics, Inc.
Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology development company | Commercial Services |
Modulo Bio, Inc.
Modulo Bio, Inc. BiotechnologyHealth Technology Discovers treatments and digital platform that harness the neuron immune system for the benefit of patients and their families | Health Technology |
Think Bioscience, Inc.
Think Bioscience, Inc. BiotechnologyHealth Technology Develops small-molecule drugs | Health Technology |
